Black Opal Ventures

AuthMind is an identity security firm focused on identifying and mitigating hidden identity risks through advanced access neural network technologies. Its platform provides a comprehensive solution for identity and cybersecurity teams, offering real-time identity security posture management and identity threat detection and response services. By addressing critical vulnerabilities such as blind spots, security gaps in identity infrastructure, and human errors in configurations, AuthMind enables enterprises to effectively combat identity-based attacks and enhance their overall security posture.

Parasail is an AI deployment networking company that provides AI products to builders and innovators for secure compute.

Conceivable Life Sciences is focused on revolutionizing in vitro fertilization (IVF) by developing the first fully automated IVF laboratory. The company employs advanced technologies, including single-cell robotics, to streamline the IVF process, making it more efficient and accessible to individuals and couples aspiring to become parents. By automating key aspects of IVF, Conceivable Life Sciences aims to democratize access to these reproductive technologies, ultimately helping more people fulfill their dreams of parenthood.

Hyro is a developer of a conversational artificial intelligence platform that simplifies user interactions across various digital channels. The platform leverages natural language understanding to create plug-and-play AI assistants that enable users to engage with information through voice or chat. By automatically building a knowledge graph from existing content, Hyro allows organizations to deploy and maintain their solutions with minimal friction, eliminating the need for extensive integration, playbooks, or training data. Additionally, the platform includes advanced analytics and conversation editing capabilities, enabling businesses to customize navigation and enhance customer engagement effectively.

Hyro is a developer of a conversational artificial intelligence platform that simplifies user interactions across various digital channels. The platform leverages natural language understanding to create plug-and-play AI assistants that enable users to engage with information through voice or chat. By automatically building a knowledge graph from existing content, Hyro allows organizations to deploy and maintain their solutions with minimal friction, eliminating the need for extensive integration, playbooks, or training data. Additionally, the platform includes advanced analytics and conversation editing capabilities, enabling businesses to customize navigation and enhance customer engagement effectively.

Optellum Ltd is a company based in Oxford, United Kingdom, specializing in the development of AI-driven clinical decision support software for lung cancer diagnosis and treatment. Founded in 2015, Optellum aims to enhance cancer care by providing an end-to-end IT platform that facilitates personalized early diagnosis and therapeutic strategies for patients at high risk of developing lung cancer, which is the most common and deadliest form of cancer. The company's innovative software identifies at-risk individuals and streamlines optimal treatment options, leveraging machine learning to analyze vast datasets from numerous healthcare professionals. Optellum's team consists of experts in medical imaging, artificial intelligence, and clinical practice, many of whom have a history of successful innovations in the medical technology sector. They are supported by an advisory board of leading clinicians and deep learning specialists, and are actively expanding their product development team to further their mission in the fight against cancer.

Empatica Inc. is a company that specializes in developing wearable medical sensor devices aimed at health monitoring, treatment, and research. Founded in 2013 and based in Cambridge, Massachusetts, Empatica's offerings include the E3 wristband, which monitors physiological signals in real-time, along with a mobile application and a web dashboard designed for stress and sleep monitoring. The company employs a combination of biosensors and artificial intelligence to analyze human physiology, providing valuable insights for patients, clinicians, and researchers. Its client base includes notable organizations such as Microsoft Research, Sony, University of Trento, and Intel.

Synteny.Ai Syntney decodes the signals of immune repertoires to help biotech research and pharma companies with disease discoveries.